German guidelines for the diagnosis and management of infective endocarditis

International Journal of Antimicrobial Agents

Volumn 29, Issue 6, 2007, Pages 643-657

[No Author Info available]

Author keywords

Guidelines; Infective endocarditis

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; FLUCYTOSINE; GENTAMICIN; OXACILLIN; PENICILLIN G; QUINOLONE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ANTICOAGULATION; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BLOOD CULTURE; CELL CULTURE; DRUG HYPERSENSITIVITY; ECHOCARDIOGRAPHY; EMBOLISM; GRAM POSITIVE BACTERIUM; HEART ABSCESS; HEART FAILURE; HEART VALVE; HEART VALVE PROSTHESIS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; MICROBIOLOGICAL EXAMINATION; NUCLEIC ACID AMPLIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SERODIAGNOSIS; SHORT SURVEY;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; ENDOCARDITIS, BACTERIAL; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; PRACTICE GUIDELINES;

EID: 34248170709     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.01.017     Document Type: Short Survey

References (106)

1. Hoen B., Alla F., Selton-Suty C., et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288 (2002) 75-81
2. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK). Clinical course of infective endocarditis in the late nineties: preliminary results of the ALKK endocarditis registry [abstract]. Eur Heart J 20 Suppl. (1999) 362
3. Task Force on Infective Endocarditis of the European Society of Cardiology. Recommendations for prevention, diagnosis and treatment of infective endocarditis. Eur Heart J 25 (2004) 267-276
4. Lorenz W, Ollenschläger G, Geradts M, Gerlach FM, Grandjour A, Helou A. Das Leitlinien-Manual. Entwicklung und Implementierung von Leitlinien in der Medizin. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 95/1. Auflage; 2001.
5. The AGREE-Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument; 2003. http://www.agreecollaboration.org [accessed 14 February 2007].
6. Trappe H.J. Leitlinien der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung. Z Kardiol 92 (2003) 689-693
7. Delbecq A.L., Van de Ven A.H., and Gustafson D.H. Group techniques for program planning (1975), Scott, Foresman and Company, Glenview, IL
8. Mügge A. Echocardiographic detection of cardiac valve vegetations and prognostic implications. Infect Dis Clin North Am 7 (1993) 877-898
9. Erbel R., Rohmann S., Drexler M., et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J 9 (1988) 43-53
10. Evangelista A., and Gonzalez-Alujas M.T. Echocardiography in infective endocarditis. Heart 90 (2004) 614-617
11. Daniel W.G., Mugge A., Martin R.P., et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 324 (1991) 795-800
12. Piper C., Hetzer R., Korfer R., Bergemann R., and Horstkotte D. The importance of secondary mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation. Eur Heart J 23 (2002) 79-86
13. Di Salvo G., Habib G., Pergola V., et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 37 (2001) 1069-1076
14. Rohmann S., Erbel R., Darius H., et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 4 (1991) 465-474
15. Mügge A., Daniel W.G., Frank G., and Lichtlen P.R. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 14 (1989) 631-638
16. Mügge A. Management of imminent emboli in endocarditis: are they predictable?. Herz 26 (2001) 391-397
17. Weinstein M.P. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 23 (1996) 40-46
18. Shah P.M., Ullmann U., Seifert H., et al. Sepsis Blutkulturdiagnostik. MiQ 3 (1997) 1-44
19. Morris A.J., Drinkovic D., Pottumarthy S., et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis 36 (2003) 697-704
20. Chuard C., Antley C.M., and Reller L.B. Clinical utility of cardiac valve Gram stain and culture in patients undergoing native valve replacement. Arch Pathol Lab Med 122 (1998) 412-415
21. Brouqui P., and Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 14 (2001) 177-207
22. Goldenberger D., Kunzli A., Vogt P., Zbinden R., and Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 35 (1997) 2733-2739
23. Lisby G., Gutschik E., and Durack D.T. Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am 16 (2002) 393-412
24. Bosshard P.P., Kronenberg A., Zbinden R., Ruef C., Bottger E.C., and Altwegg M. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37 (2003) 167-172
25. Millar B., Moore J., Mallon P., et al. Molecular diagnosis of infective endocarditis-a new Duke's criterion. Scand J Infect Dis 33 (2001) 673-680
26. Lepidi H., Durack D.T., and Raoult D. Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin North Am 16 (2002) 339-361 ix
27. Murdoch D.R. Diagnosis of Legionella infection. Clin Infect Dis 36 (2003) 64-69
28. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
29. Naber C.K., and Erbel R. Diagnosis of culture negative endocarditis: novel strategies to prove the suspect guilty. Heart 89 (2003) 241-243
30. Habib G., Derumeaux G., Avierinos J.F., et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 33 (1999) 2023-2029
31. Kupferwasser L.I., Darius H., Muller A.M., et al. Diagnosis of culture-negative endocarditis: the role of the Duke criteria and the impact of transesophageal echocardiography. Am Heart J 142 (2001) 146-152
32. Rognon R., Kehtari R., and Francioli P. Individual value of each of the Duke criteria for the diagnosis of infective endocarditis. Clin Microbiol Infect 5 (1999) 396-403
33. Uh Y., Shin D.H., Jang I.H., et al. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea. J Antimicrob Chemother 53 (2004) 1095-1097
34. Stein D.S., and Nelson K.E. Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Rev Infect Dis 9 (1987) 908-916
35. Karchmer A.W., Moellering Jr. R.C., Maki D.G., and Swartz M.N. Single-antibiotic therapy for streptococcal endocarditis. JAMA 241 (1979) 1801-1806
36. Malacoff R.F., Frank E., and Andriole V.T. Streptococcal endocarditis: single vs combination therapy. JAMA 241 (1979) 1807-1810
37. Wilson W.R., Thompson R.L., Wilkowske C.J., Washington J.A., Giuliani E.R., and Geraci J.E. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA 245 (1981) 360-363
38. Tan J.S., Kaplan S., Terhune Jr. C.A., and Hamburger M. Successful two week schedule for penicillin-susceptible S. viridans endocarditis. Lancet 2 (1971) 1340-1343
39. Roberts S.A., and Lang S.R. Short course treatment of penicillin-susceptible viridans streptococcal endocarditis with penicillin and gentamicin. Inf Dis Clin Pract 2 (1993) 191-194
40. Woolfe J.C., and Johnson W.D. Penicillin-sensitive streptococcal endocarditis: in vitro and clinical observations on penicillin-streptomycin therapy. Ann Intern Med 81 (1974) 178-181
41. Parrillo J.E., Borst G.C., Mazur M.H., et al. Endocarditis due to resistant viridans streptococci during dental penicillin prophylaxis. N Engl J Med 300 (1979) 296-300
42. Friedberg C.K., Rosen K.M., and Bienstock P.A. Vancomycin therapy for enterococcal and Streptococcus viridans endocarditis. Successful treatment of six patients. Arch Intern Med 122 (1968) 134-140
43. Wilson A.P., and Gaya H. Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases. J Antimicrob Chemother 38 (1996) 507-521
44. Presterl E., Graninger W., and Georgopoulos A. The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria. J Antimicrob Chemother 31 (1992) 755-766
45. Francioli P., Etienne J., Hoigne R., Thys J.P., and Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 267 (1992) 264-267
46. Sexton D.J., Tenenbaum M.J., Wilson W.R., et al. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 27 (1998) 1470-1474
47. Kresken M., and Hafner D. Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975-1995. Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy. Infection 27 Suppl. 2 (1999) S2-S8
48. Fruden T.R., and Munriff S.S. Emergence of vancomycin-resistant endocarditis in New York City. Lancet 342 (1993) 76
49. Wilson W.R., Wilkowske C.J., Wright A.J., Sande M.A., and Geraci J.E. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med 100 (1984) 816-823
50. Schmit J.L. Efficiency of teicoplanin for enterococcal infection: 63 cases and review. Clin Infect Dis 15 (1992) 302-306
51. Westenfelder G.O., Paterson P.J., Reisberg B.E., and Carlson G.M. Vancomycin-streptomycin synergism in enterococcal endocarditis. JAMA 223 (1973) 37-40
52. Babcock H.M., Ritchie D.J., Christiansen E., Starlin R., Little R., and Stanley S. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis 32 (2001) 1373-1375
53. Thompson R.L., Lavin B., and Talbot G.H. Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin. South Med J 96 (2003) 818-820
54. Patterson J.E., Sweeney A.H., Simms M., et al. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74 (1995) 191-200
55. Chambers H.F., Korzeniowski O.M., and Sande M.A. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) 62 (1983) 170-177
56. Witte W., Braulke C., Cuny C., Heuck D., and Kresken M. Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals. Infect Control Hosp Epidemiol 22 (2001) 683-686
57. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:565-7.
58. Korzeniowski O., and Sande M.A. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 97 (1982) 496-503
59. Small P.M., and Chambers H.F. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34 (1990) 1227-1231
60. Karchmer A.W., Archer G.L., and Dismukes W.E. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 5 Suppl. 3 (1983) S543-S548
61. Archer G.L., Johnston J.L., Vazquez G.J., and Haywood III H.B. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies. Rev Infect Dis 5 Suppl. 3 (1983) S538-S542
62. Karchmer A.W., Archer G.L., and Dismukes W.E. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiological and clinical observations as guides to therapy. Ann Intern Med 98 (1983) 447-453
63. Lucet J.C., Herrmann M., Rohner P., Auckenthaler R., Waldvogel F.A., and Lew D.P. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 34 (1990) 2312-2317
64. Rouse M.S., Wilcox R.M., Henry N.K., Steckelberg J.M., and Wilson W.R. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 34 (1990) 273-276
65. Vandenesch F., Etienne J., Reverdy M.E., and Eykyn S.J. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 17 (1993) 871-876
66. Wilson W.R., Karchmer A.W., Dajani A.S., et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms, American Heart Association. JAMA 274 (1995) 1706-1713
67. Wieland M., Lederman M.M., Kline-King C., et al. Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature. Medicine (Baltimore) 65 (1986) 180-189
68. Reyes M.P., Brown W.J., and Lerner A.M. Treatment of patients with Pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) 57 (1978) 57-67
69. Fantin B., Farinotti R., Thabaut A., and Carbon C. Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. J Antimicrob Chemother 33 (1994) 563-569
70. Pefanis A., Giamarellou H., Karayiannakos P., and Donta I. Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother 37 (1993) 308-313
71. Geraci J.E., and Wilson W.R. Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo Clin Proc 57 (1982) 145-148
72. Ellis M.E., Al Abdely H., Sandridge A., Greer W., and Ventura W. Fungal endocarditis: evidence in the world literature 1965-1995. Clin Infect Dis 32 (2001) 50-62
73. Donal E., Abgueguen P., Coisne D., et al. Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart 86 (2001) 179-182
74. Muehrcke D.D., and Lytle R.W. Surgical and long term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 60 (1995) 538-543
75. Duroux-Vouilloz C., Praz G., Francioli P., and Peter O. Q-fever endocarditis, clinical presentation and serological follow-up of 21 patients. Schweiz Med Wochenschr 128 (1998) 740-744 [in French]
76. Siegman-Igra Y., Kaufman O., Keysary A., Rzotkiewicz S., and Shalit I. Q-fever endocarditis in Israel and a worldwide review. Scand J Infect Dis 29 (1997) 41-49
77. Sanchez-Recalde A., Mate I., Lopez E., et al. Coxiella burnetii endocarditis: long-term clinical course in 20 patients. Rev Esp Cardiol 53 (2000) 940-946 [in Spanish]
78. Jacobs F., Abramowicz D., Vereerstraeten P., Le Clerc J.L., Zech F., and Thys J.P. Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis 12 (1990) 740-744
79. Raoult D., Fournier P.E., Drancourt M., et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med 125 (1996) 646-652
80. Drancourt M., Mainardi J.L., Brouqui P., et al. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med 332 (1995) 419-423
81. Raoult D. Afebrile blood culture-negative endocarditis. Ann Intern Med 131 (1999) 144-146
82. Saravolatz L.D., Burch K.H., Quinn E.L., Cox F., Madhavan T., and Fisher E. Polymicrobial infective endocarditis: an increasing clinical entity. Am Heart J 95 (1978) 163-168
83. Chambers H.F., Miller R.T., and Newman M.D. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 109 (1988) 619-624
84. Ribera E., Gomez-Jimenez J., Cortes E., et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 125 (1996) 969-974
85. Heldman A.W., Hartert T.V., Ray S.C., et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 101 (1996) 68-76
86. Niebel J. Infective endocarditis in immune-compromised patients. In: Horstkotte D., and Bodnar E. (Eds). Current Issues in Heart Valve Disease: Infective Endocarditis (1991), ICR Publishers, London, UK 154-163
87. Nahass R.G., Weinstein M.P., Bartels J., and Gocke D.J. Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis 162 (1990) 967-970
88. Pulvirenti J.J., Kerns E., Benson C., Lisowski J., Demarais P., and Weinstein R.A. Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression. Clin Infect Dis 22 (1996) 40-45
89. Stamboulian D., Bonvehi P., Arevalo C., et al. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis 13 Suppl. 2 (1991) S160-S163
90. Tornos P., Almirante B., Mirabet S., Permanyer G., Pahissa A., and Soler-Soler J. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 159 (1999) 473-475
91. Chan K.L., Dumesnil J.G., Cujec B., et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 42 (2003) 775-780
92. Netzer R.O., Altwegg S.C., Zollinger E., Tauber M., Carrel T., and Seiler C. Infective endocarditis: determinants of long term outcome. Heart 88 (2002) 61-66
93. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
94. DiDomenico R.J., Park H.Y., Southworth M.R., et al. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother 38 (2004) 649-660
95. Graupner C., Vilacosta I., SanRoman J., et al. Periannular extension of infective endocarditis. J Am Coll Cardiol 39 (2002) 1204-1211
96. Choussat R., Thomas D., Isnard R., et al. Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. Eur Heart J 20 (1999) 232-241
97. Rohmann S., Seifert T., Erbel R., et al. Identification of abscess formation in native-valve infective endocarditis using transesophageal echocardiography: implications for surgical treatment. Thorac Cardiovasc Surg 18 (1991) 353-359
98. Chan K.L. Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. CMAJ 167 (2002) 19-24
99. Rohmann S., Erbel R., Darius H., Makowski T., and Meyer J. Effect of antibiotic treatment on vegetation size and complication rate in infective endocarditis. Clin Cardiol 20 (1997) 132-140
100. Vilacosta I., Graupner C., San Roman J.A., et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 39 (2002) 1489-1495
101. Horstkotte D., Schulte H.D., Niehues R., Klein R.M., Piper C., and Strauer B.E. Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 2 (1993) 212-222
102. Horstkotte D., Piper C., Wiemer M., et al. Emergency heart valve replacement after acute cerebral embolism during florid endocarditis. Med Klin (Munich) 15 (1998) 284-293 [in German]
103. Chastre J., and Trouillet J.L. Early infective endocarditis on prosthetic valves. Eur Heart J 16 Suppl. B (1995) 32-38
104. Piper C., Körfer R., and Horstkotte D. Prosthetic valve endocarditis. Heart 85 (2001) 590-593
105. Hagl C., Galla J.D., Lansman S.L., et al. Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated?. Ann Thorac Surg 74 (2002) S1781-S1785
106. Lytle B.W., Sabik J.F., Blackstone E.H., Svensson L.G., Pettersson G.B., and Cosgrove III D.M. Reoperative cryopreserved root and ascending aorta replacement for acute aortic prosthetic valve endocarditis. Ann Thorac Surg 74 (2002) S1754-S1757